About Autism Biotech
Autism Biotech is a company based in Belfast (United Kingdom) founded in 2011 by Detlef Siebert Gerd and Suzanne Saffie-Siebert. It operates as a B2B. Autism Biotech has raised $51.3 thousand across 1 funding round from investors including Co-Fund NI, Schneider Investment Associates and Siamak Shahnooshi. Autism Biotech operates in a competitive market with competitors including Lineagen, Linus Biotechnology, MARAbio, Pediatric Bioscience and SensOmics, among others.
- Headquarter Belfast, United Kingdom
- Founders Detlef Siebert Gerd, Suzanne Saffie-Siebert
- SectorsHealthcare
- Website autism-biotech.com
- Legal Name Autism Biotech Ltd
- Total Equity Funding$51.3K (USD)
in 1 rounds
- Latest Funding Round$51.3K (USD), Seed
Aug 2018
- InvestorsCo-Fund NI
& 3 more
Funding Insights of Autism Biotech
Autism Biotech has successfully raised a total of $51.3K through 1 strategic funding round. The most recent funding activity was a Seed round of $51.3 thousand completed in August 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $51,300
- Total Rounds 1
- Last Round Seed — $51,300
- First Round $51,300
(Aug 2018)
- Investors Count 4
All 1 funding rounds of Autism Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2018 | $51,300 | Seed | $194,683 | Co-Fund NI, Schneider Investment Associates |
Last known valuation $194,683 (Aug 2018). 4 investors in total: 2 institutional and 2 angel.
Investors in Autism Biotech
Autism Biotech has secured backing from 4 investors, including venture fund and angel investors. Prominent investors backing the company include Co-Fund NI, Schneider Investment Associates and Siamak Shahnooshi.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | cofundni.com | - | |
- | – | schneiderinvestmentassociates.com | - | |
SS Siamak Shahnooshi | - | – | unknown_86acef65b99140c3a | - |
DS Detlef Siebert Gerd | - | – | unknown_2b419d51a8904146a | - |
Investor details for Autism Biotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Autism Biotech
2 people are tracked at Autism Biotech (2 in leadership).
| Name | Role | Group |
|---|---|---|
Detlef Siebert Gerd | Co-Founder | Leadership |
Suzanne Saffie-Siebert | Co-Founder | Leadership |
Complete people profiles for Autism Biotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Autism Biotech
2 dated milestones of Autism Biotech across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Autism Biotech is founded.
- Funding First funding round of $51K.
Competitors of Autism Biotech
Autism Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lineagen, Linus Biotechnology, MARAbio, Pediatric Bioscience and SensOmics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lineagen.com | 2002 | Salt Lake, United States | $66.93M | 40 | Sequencing-based diagnostic tests and services for autism are provided. | |
| linusbio.com | 2020 | New York, United States | $47.65M | – | Developer of diagnostic tests for central nervous system and gastrointestinal disorders | |
| marabio.com | 2016 | Salt Lake, United States | $19.06M | – | A blood test for maternal autoantibody-related autism is developed. | |
| pediatricbioscience.com | 2006 | Sacramento, United States | $2.44M | – | Provides blood biomarker-based diagnostics for autism spectrum disorders. | |
| sensomics.com | 2007 | Toronto, Canada | – | – | Precision medicine for children's health is provided through genomic integration. | |
| neuropointdx.com | 2006 | Madison, United States | – | – | Metabolomics for neuro-developmental disorders | |
| fbbbio.com | 2020 | Coralville, United States | $401,000 | – | In-vitro diagnostic tests for COVID-19 and neurological diseases are developed. | |
| metabolus.com | 2015 | San Diego, United States | – | 33 | Develops diagnostics for neurodegenerative and neuropsychiatric disorders. | |
| neuraclegen.com | 2018 | Seoul, South Korea | – | – | Develops gene therapies using adeno-associated virus technology to treat various diseases. |
Detailed competitors of Autism Biotech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Autism Biotech
10 companies that operate in the same segment as Autism Biotech (Diagnostics & Lab Tech), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceuticals and diagnostics kits are developed for various diseases. | 1896 | Basel, Basel-stadt, Switzerland | – | USD 77.61 B | 103,250 | |
Point-of-care and laboratory blood analyzers are developed by EKF. | 1990 | Penarth, Wales, United Kingdom | USD 178.63 K | USD 69.43 M | 303 | |
Blood testing services are offered using finger-prick microsamples. | 2017 | Austin, Texas, United States | USD 37.7 M | – | – | |
Manufactures clinical diagnostic test kits | 1971 | Irvine, California, United States | – | USD 4.45 M | 54 | |
Biomarker-based diagnostic solutions for cancer and cardiovascular diseases are developed. | 2002 | Hennigsdorf, Brandenburg, Germany | USD 36.14 M | – | – | |
Diagnostic instrumentation and assays | 1987 | Puteaux, Hauts-de-seine, France | – | – | – | |
Manufacturer of Laboratory equipment | 1955 | Norwood, Massachusetts, United States | – | – | – | |
Cloud based diagnostics platform for point of care diagnosing | 2014 | Waltham, Massachusetts, United States | USD 703.91 M | USD 115.02 K | 9 | |
Diagnostics technology for infectious diseases and health monitoring is provided. | 2012 | Hong Kong, China | USD 34 M | – | – | |
Global leader for In Vitro Diagnostic | 1959 | Barcelona, Catalonia, Spain | – | USD 61.01 M | 346 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Autism Biotech
Autism Biotech was founded in 2011 and raised its 1st funding round 7 years after it was founded.
Autism Biotech is headquartered in Belfast, United Kingdom. It is registered at Belfast, Northern Ireland, United Kingdom.
Autism Biotech is a funded company, having raised a total of $51.3K across 1 funding round to date. The company's 1st funding round was a Seed of $51.3K, raised on Aug 2018.
Autism Biotech, led by Detlef Siebert Gerd as Co-Founder, Suzanne Saffie-Siebert as Co-Founder, specializes in providing healthcare solutions, advancing biotech innovations, offering diagnostic solutions, and autism testing. Develops biochemical tests for early autism diagnosis. The team drives innovation, quality service, and sustainable practices to achieve excellence and client satisfaction.
Autism Biotech's top competitors include Linus Biotechnology, MARAbio and Lineagen.
Autism Biotech has 4 investors. Key investors include Co-Fund NI, Schneider Investment Associates, Siamak Shahnooshi, and Detlef Siebert Gerd.
The valuation of Autism Biotech is $194.68K as of Aug 2018.
Autism Biotech operates through Autism Biotech Ltd.